Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Anavex starts 30mg dose step in Alzheimer’s drug Phase 1 trial
The trial which intended to establish the maximum tolerated single dose, safety and pharmacokinetics of ANAVEX 2-73 is being conducted in Germany in partnership with ABX-CRO. In the
The trial which intended to establish the maximum tolerated single dose, safety and pharmacokinetics of ANAVEX 2-73 is being conducted in Germany in partnership with ABX-CRO. In the
Zafgen’s first generation product, ZGN-433, is being studied its use as a pharmacological alternative to bariatric surgery in the treatment of severe obesity. Zafgen’s lead molecule is being
Opiorphin, a 5-amino acids peptide initially discovered from human saliva, was shown to be as efficient as morphine when tested in animal models of pain but without any
MabiobCD20 is a monoclonal antibody used to treat blood cancer, lymphomas and leukemias. The clinical program will involve 600-700 patients and will last approximately two years. Mabion president
The Pregabalin capsules are the generic version of Lyrica capsules of CP Pharmaceuticals. Lyrica (Pregabalin) capsules are indicated as a treatment of neuropathic pain linked with diabetic peripheral
Under the pact, Evotec will use its drug discovery technologies for identifying small molecules against the UCB selected targets. The molecules will be further optimised and progressed through
Dr Reddy’s‘ Mexican facility manufactures intermediates and active pharmaceutical ingredients (APIs) for use in generic medicines. The FDA’s decision follows the issuance of warning letter to the company
The launching of the capsules, bioequivalent generic version of Lotrel capsules, follows approval from the US Food and Drug Administration (FDA). The capsules are available in 100 count
The placebo-controlled, double-blind Phase 2a study expects to include around 50 patients of age 55-85 who have been diagnosed with mild Alzheimer’s disease. Currently, MSDC-0160 is being examined
Wellstat’s uridine triacetate is indicated as a treatment for accidental exposure to the chemotherapeutic 5-fluorouracil (5-FU). The agreement allows BTG to mark, sell and distribute uridine triacetate in